» Articles » PMID: 36443867

Age Patterns of Nonalcoholic Fatty Liver Disease Incidence: Heterogeneous Associations with Metabolic Changes

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2022 Nov 29
PMID 36443867
Authors
Affiliations
Soon will be listed here.
Abstract

Background: As the nonalcoholic fatty liver disease (NAFLD) epidemic matures, understanding how metabolic changes in NAFLD development vary over the age distribution is important to guide precise prevention. We aimed to clarify metabolic trends in age-specific NAFLD incidence.

Methods: We conducted a 4-year longitudinal retrospective cohort study enrolling 10,240 consecutive healthy individuals who received annual physical examination during 2012-2019. Baseline and dynamic changes in metabolism and hepatic steatosis determined with ultrasound were collected and analyzed stratified by age into the following groups: 20-34, 35-49, 50-64, and over 65 years.

Results: Overall, 1701 incident NAFLD participants (16.6%) were identified. Adjusted Cox regression analysis showed that the baseline and increased body mass index were the main risk factors for NAFLD in people ≤ 65 years old. Baseline high-density lipoprotein (HR = 0.56; 95% CI 0.39-0.78) was a protective factor for newly onset NAFLD in the 50-to-64-year-old group, while baseline SBP (HR = 1.03; 95% CI 1.01-1.05), baseline uric acid (HR = 1.04; 95% CI 1.01-1.07), triglyceride increase (HR = 4.76; 95% CI 3.69-6.14), fasting blood glucose increase (HR = 1.32; 95% CI 1.06-1.65) were independently associated with incident NAFLD in over-65-year-old group.

Conclusions: NAFLD incidence attributable to potentially metabolic risk factors varied substantially across age groups in a cohort of Chinese people. The adoption of age targeted metabolic prevention strategies might reduce the burden of NAFLD.

Citing Articles

Burden of NASH related liver cancer from 1990 to 2021 at the global, regional, and national levels.

Li S, Li S, Guan L, Li M, Zhao J, Wu M Front Nutr. 2025; 12:1510563.

PMID: 39931368 PMC: 11807830. DOI: 10.3389/fnut.2025.1510563.


Metabolic Dysfunction-Associated Steatotic Liver Disease in Patients with Inflammatory Bowel Diseases: A Pilot Study.

Abenavoli L, Spagnuolo R, Scarlata G, Gambardella M, Boccuto L, Mendez-Sanchez N Life (Basel). 2024; 14(10).

PMID: 39459526 PMC: 11509059. DOI: 10.3390/life14101226.


Impact of diet intervention on visceral adipose tissue and hepatic fat in patients with obesity or type 2 diabetes: a randomized trial.

Krittayaphong R, Treesuwan W, Pramyothin P, Songsangjinda T, Kaolawanich Y, Srivanichakorn W Sci Rep. 2024; 14(1):21388.

PMID: 39271914 PMC: 11399339. DOI: 10.1038/s41598-024-72246-w.


Impact of Korean Military Service on the Prevalence of Steatotic Liver Disease: A Longitudinal Study of Pre-enlistment and In-Service Health Check-Ups.

Lee J, Jung J, Choi S, Ha B, Yang H, Sung P Gut Liver. 2024; 18(5):888-896.

PMID: 38953118 PMC: 11391135. DOI: 10.5009/gnl240077.


From NAFLD to NASH: Understanding the spectrum of non-alcoholic liver diseases and their consequences.

Samy A, Kandeil M, Sabry D, Abdel-Ghany A, Mahmoud M Heliyon. 2024; 10(9):e30387.

PMID: 38737288 PMC: 11088336. DOI: 10.1016/j.heliyon.2024.e30387.


References
1.
Polyzos S, Kountouras J, Mantzoros C . Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2018; 92:82-97. DOI: 10.1016/j.metabol.2018.11.014. View

2.
Chalasani N, Younossi Z, Lavine J, Charlton M, Cusi K, Rinella M . The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2017; 67(1):328-357. DOI: 10.1002/hep.29367. View

3.
Yamada G, Hagiwara Y, Kimura T, Takeuchi Y, Oba K, Masuda K . Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals. Am J Gastroenterol. 2021; 116(4):733-740. DOI: 10.14309/ajg.0000000000001030. View

4.
Westeneng H, van Veenhuijzen K, van der Spek R, Peters S, Visser A, van Rheenen W . Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. Lancet Neurol. 2021; 20(5):373-384. DOI: 10.1016/S1474-4422(21)00042-9. View

5.
Li J, Zou B, Yeo Y, Feng Y, Xie X, Lee D . Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2019; 4(5):389-398. DOI: 10.1016/S2468-1253(19)30039-1. View